Malaria expert predicts vaccine will spur innovation
In October, the World Health Organization (WHO) for the first time recommended a broad rollout of a vaccine that protects against Plasmodium falciparum, the deadliest malaria parasite globally and the most prevalent in Africa.
Vaccine researcher Kizzmekia Corbett wins top honor for federal service
Harvard Chan School's Kizzmekia Corbett has been named a “Federal Employee of the Year” for conducting groundbreaking vaccine research while working at the National Institutes of Health.
Eric Rubin, Renee Salas elected to National Academy of Medicine
Two researchers from Harvard T.H. Chan School of Public Health, Eric Rubin and Renee Salas, have been elected to the National Academy of Medicine.
How to trick-or-treat safely during the pandemic
The Centers for Disease Control and Prevention has said it’s OK for kids to go trick-or-treating this Halloween—carefully.
WHO’s historic recommendation for malaria vaccine spurs hope
The long and at times faltering fight against malaria hit a turning point this week when the World Health Organization (WHO) recommended a broad rollout of a vaccine that protects against Plasmodium falciparum, the deadliest malaria parasite globally…
Kizzmekia Corbett is just getting started
She played a key role in developing the Moderna COVID-19 vaccine. Now at the Harvard Chan School, she’s turning to the pathogens that may spark the next pandemic.
AIDS at 40: The endgame of a global scourge approaches
Phyllis Kanki, Mary Woodard Lasker Professor of Health Sciences, reflects on the successes and failures of the global response to HIV/AIDS, and the work left to do to finally end the disease.
Flaminia Catteruccia named Howard Hughes Medical Institute investigator
For immediate release: Thursday, September 23, 2021 Boston, MA ─ The Howard Hughes Medical Institute (HHMI) has named Flaminia Catteruccia, professor of immunology and infectious diseases at Harvard T.H. Chan School of Public Health, as one of 33 new…
Understanding the new recommendations on COVID-19 boosters
In this Q&A, Eric Rubin discusses the FDA advisory panel vote on recommendations for COVID-19 boosters.
Perspective: The intersection of public health and clinical medicine is changing
To achieve the World Health Organization’s goal of helping provide “the highest attainable standard of health” for individuals, it’s time to rethink the divisions between public health and clinical medicine, especially preventive medicine, according to an August 5,…
